News & AnalysisAlloy Therapeutics snags $75m Series CAlloy Therapeutics, a biotechnology ecosystem company, has secured $75 million in Series C financing.ByIris Dorbian2 April 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsTechnologyBriefs